1 / 32

MANAGEMENT OF A SEPTICEMIC FOAL

MANAGEMENT OF A SEPTICEMIC FOAL. Jenna Donaldson PO Box 1200 Nobleton, Ontario, Canada L0G 1N0 Mentor: Dr. Joanne Hewson, DVM, PhD, DACVIM Ontario Veterinary College, University of Guelph Guelph, Ontario, Canada. SIGNALMENT & HISTORY. Thoroughbred colt bred for racing

svivian
Télécharger la présentation

MANAGEMENT OF A SEPTICEMIC FOAL

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MANAGEMENT OF A SEPTICEMIC FOAL Jenna Donaldson PO Box 1200 Nobleton, Ontario, Canada L0G 1N0 Mentor: Dr. Joanne Hewson, DVM, PhD, DACVIM Ontario Veterinary College, University of Guelph Guelph, Ontario, Canada

  2. SIGNALMENT & HISTORY • Thoroughbred colt bred for racing • Born April 30th, 2011 - normal, unassisted parturition • Received ~100 mL of colostrum in first 12 hours • 2nd foal from dam, who rejected first foal • Did not allow this foal to nurse without restraint

  3. FURTHER HISTORY • May 2nd, 2011 (2 days old) • IgG inadequate (SNAP test: <400 mg/dL) • 1L of commercial equine plasma IV • Began therapy with trimethoprim-sulfa IV • May 5th, 2011 (6 days old) • Low heart rate and poor body condition score • rDVM gave procaine penicillin G and amikacin IM • Referred to the Ontario Veterinary College

  4. INITIAL FINDINGS at OVC • Mentation: • Non-responsive to painful stimulus • Respiratory System: • Bradypnea: 2-4 breaths/min • Irregular rate w/ periods of apnea • Cardiovascular System: • Bradycardia: 30 beats/min • Irregular rhythm • Very weak femoral pulse • CRT: prolonged - >3 seconds • Mucus membranes: petechiae, icterus • Severe hypothermia: <33.0°C

  5. CARDIOPULMONARY FAILUREIN A NEONATAL FOAL Respiratory arrest/ nonperfusing bradycardia Pulseless electrical activity Asystole Respiratory failure Systemic disease/sepsis* and hypothermia -> ↓ cardiac output Hypoxic acidosis/ ↓ O2 delivery Clinical signs at presentation indicated impending cardiopulmonary arrest *Cardiopulmonary arrest in neonatal foals is rarely due to 1° cardiac failure

  6. INITIAL THERAPY – ABC’s • Airway • Orotracheally intubated w/ 10mm cuffed tube • Started oxygen therapy – 5L O2/minute • Breathing • Manually ventilated with Ambubag • 8-10 breaths per minute • Circulation • Emergency drug therapy via cephalic vein (see next slide) • Initiated active warming (‘Bear Hugger’ warm air blanket, hair dryer) • Gained IV access – placed over-the-wire catheter in external jugular vein • Monitored heart rhythm/response to therapy with ECG, SpO2, and ETCO2

  7. EMERGENCY DRUGS • Route of Administration: • IV ideal – alternatives: intraosseous or intratracheal (2x doses) • Atropine: anticholinergic (muscarinic receptor antagonist) • Attenuates vagally-mediated bradycardia (0.01-0.02 mg/kg) • Epinephrine: mixed α- and β-adrenergic agonist • Low dose initially (0.01 mg/kg) then high dose (0.1 mg/kg) if no response • Vasopressin: endogenous vasoactive peptide hormone • Potent nonadrenergic vasconstrictor, replaces use of epinephrine (0.2-0.8 U/kg) • Ephedrine: indirect-actingsympathomimetic (0.05-0.1 mg/kg) • ↑activity of catecholamines – useful in neonates (↓ vasomodulatory ability) esp. if septicemic • Lidocaine: Na+ channel blocker • Anti-arrhythmic properties, especially post-arrest (2 mg/kg IV bolus then 20-50 ug/kg/min CRI)

  8. INITIAL EMERGENCY THERAPY • 12:40: Intubated, started manual ventilation • 12:45: Ephedrine 0.1 mg/kg, atropine 0.02 mg/kg IV • No change in heart rate (30 bpm) • Started active warming due to severe hypothermia • ↓ effect of anticholinergic in hypothermic patients • 12:50: Ephedrine 0.1 mg/kg IV (2nd dose) • HR increased to 100 bpm, normal ECG rhythm • 12:55: Initiated fluid therapy after jugular catheter placement • Isotonic crystalloid (Plasmalyte A) • 50 mL/kg at shock rate (90 mL/kg/hr) • Synthetic colloid (Pentaspan) • 10 mL/kg bolus

  9. INITIAL MONITORING • Heart rate/rhythm: ECG, pulse palpation • Blood pressure: indirect (Doppler – systolic BP) • Oxygen saturation: pulse oximeter – probe on tongue • Reduced accuracy due to poor perfusion and hypothermia • Respiratory rate/efficiency: capnography • Arterial blood gas/electrolytes: (obtained from lateral metatarsal artery) Most significant blood gas/e-lyte findings: • Severe hypoxemia/↓ oxygen saturation • Severe hypoglycemia • Mild hypercapnia

  10. POST-RESUSCITATION • 13:40: 1 hr post initial resuscitation • HR ↓ rapidly to 50 bpm – atropine 0.02 mg/kg IV • HR ↑ to 80 bpm • 13:45: multifocal VPCs, bigeminal rhythm • Due to hypothermia and sepsis • Treatment: lidocaine 2 mg/kg bolus IV x 2 • Started CRI – 20 ug/kg/min • 14:30: Repeat arterial blood gas: K+ - 3.0 • Started KCl CRI – 0.5 mEq/kg/hr to prevent hypokalemia-induced cardiac abnormalities • 14:45: HR ↓ rapidly to 55 bpm • Bradycardia due to systemic sepsis/poor perfusion • Glycopyrrolate 5 ug/kg IV -> HR ↑ to 80 bpm

  11. COMPLETE PHYSICAL EXAM (following stabilization) • Recumbency • Depressed mentation • Hypothermia: 34.6°C (Normal: 37.0-39.0°C) • Clotted blood in left nostril, on rectal thermometer • Mucus membranes: petechiae, icterus present • Multiple decubital ulcers on bony prominences • Poor body condition (1/5) • Absent borborgymi Mucus membranes petechiation (Photo courtesy Dr. Ashley Whitehead) Photo courtesy Dr. Ashley Whitehead

  12. DIAGNOSTIC PLAN Blood culture • Considered the gold standard for diagnosing septicemia; limited sensitivity • Utility limited by turnaround time Sepsis score • Developed to ‘predict’ sepsis while waiting for blood culture results • Early studies: very high sens./spec. • Recent re-evaluation: lower results Complete Database • Complete blood count • Biochemistry profile • Coagulation panel • Urinalysis Rationale: accurate diagnosis on the basis of physical exam alone is often difficult in neonatal foals – a complete database is generally required for discernment of organ function, appropriate therapeutic measures, and offering prognoses Rationale: clinical signs in this foal suggest disseminated intravascular coagulation (DIC) – a secondary manifestation of underlying disease such as sepsis

  13. LABORATORY FINDINGS – COMPLETE BLOOD COUNT *Note: laboratory-specific reference ranges for adult horses Significant Findings/Interpretation: • Leukopenia/neutropenia w/ toxic changes: acute inflammatory process (localized or septicemia) • Thrombocytopenia: ↓ production (bone marrow suppression), ↑ destruction (immune-mediated) or consumption (trauma or DIC) • ↓MCHC/RDW/monocytosis: normal in neonatal foals (lower ref. range than adults)

  14. LABORATORY FINDINGS – BIOCHEMISTRY PROFILE (PART I) *Note: laboratory-specific reference ranges for adult horses Significant Findings/Interpretation: • ↓Ca+: 2° to ↓albumin (protein-bound) • ↑P: physiologic in young animals, reflects bone metabolism • ↓Cl-: low normal – not clinically relevant • ↑Mg: not clinically relevant - serum level poorly reflects body levels • ↓TP/albumin/globulins: • ↓ production or ↑ loss • ↑ Urea w/ low-normal creatinine: • Gastrointestinal hemorrhage 2° to DIC • Catabolic state (protein metabolism) • Azotemia – pre-renal or renal (refer to urine specific gravity)

  15. LABORATORY FINDINGS – BIOCHEMISTRY PROFILE (PART II) *Note: laboratory-specific reference ranges for adult horses † Transient hyperglycemia 2° to resuscitation therapy - note initial blood gas findings Significant Findings/Interpretation: • ↑Bilirubin (all fractions): • Functional cholestasis due to sepsis • Slight ↑ may be physiologic in neonates • ↑ALP: reflects bone metabolism in young animals, can indicate hepatocellular damage • ↓AST: low enzyme levels are not clinically relevant • ↑CK: recumbency, IM injections prior to referral • ↑GLDH: indicates hepatocellular necrosis • i.e. 2° to hypoxia (↓ hepatic perfusion) • ↑ Haptoglobin/serum amyloid A: increase acute phase proteins -> inflammatory process

  16. LABORATORY FINDINGS – COAGULATION PANEL Significant Findings/Interpretation: • ↑PT: defect in extrinsic and/or common pathways • ↑PTT: defect in intrinsic and/or common pathways • ↑Fibrinogen: acute phase protein -> inflammatory process, localized or septicemia

  17. LABORATORY FINDINGS – URINALYSIS Free-catch sample at 13:30 Significant Findings/Interpretation: • Isosthenuria: not clinically relevant - sample collected following significant fluid therapy, result was judged to be appropriate for the clinical situation • Glucosuria: (confirmed w/ Clinitest tablets) – not clinically relevant - transient saturation of renal threshold following resuscitation therapy

  18. SEPSIS SCORE 13 √ 0 4.1 0 Sepsis Scoring • A score of 12 or higher has a positive predictive value of 93% • A score of 11 or lower has a negative predictive value of 88% 0 2 0 2.9 0.5* 2* <4 3-4 2 1 2 0 * Refers to original arterial blood gas measurement, prior to resuscitation therapy 0 0 12-13

  19. COMPLETE PROBLEM LIST Physical Exam • Depressed mentation* • Dehydration (approx 7%)* • Hypothermia • Icterus • Petechiae* • Bleeding from rectum/nares* • Poor body condition • Absent borborgymi • Decubital ulceration Arterial Blood Gas/Electrolytes • Hypoxemia* • Hypercapnia* • Hypoglycemia* • Complete Blood Count • Leukopenia/neutropenia* • ↓ Monocytes • Thrombocytopenia* • ↓MPV • Biochemistry Profile • Electrolytes: • ↑P, ↓Ca, ↑ Mg, ↓Cl • Liver enzymes: • ↑GLDH • ↑ ALP (also bone activity) • Muscle enzymes: • ↑CK • ↑BUN • ↓ TP/albumin/globulins* • ↑Total/conj/unconj bilirubin • ↑Serum Amyloid A* • Coagulation Profile • ↑Fibrinogen* • ↑PT* • ↑PTT* *Denotes most critical problems

  20. DIFFERENTIAL DIAGNOSES FOR MOST CRITICAL PROBLEMS • ↓Total protein, albumin, globulins: • ↓’Production’ • Failure of passive transfer • Hypoxic hepatic necrosis • ↑Loss • Septicemia • Renal failure • Leukopena, neutropenia, toxic changes, ↑haptoglobin, ↑serum amyloid A, ↑fibrinogen: • Acute inflammation • Sepsis Depressed mentation: • Septicemia • Hypoxic ischemic encephalopathy • Metabolic disturbances - hypoglycemia, hypoxia, acidosis Petechiae, bleeding from rectum/nares, thrombocytopenia, ↑PT, ↑PTT: • Disseminated intravascular coagulation (DIC) • Septicemia

  21. FINAL DIAGNOSIS: SEPTICEMIA 2° TO FAILURE OF PASSIVE TRANSFER The most common cause of increased mortality in foals, often causing weakness and depression but few other clinical signs until severe systemic compromise/death Predisposing Factors - Septicemia • Prenatal causes • Maternal illness (i.e. placentitis) • Dystocia • Postnatal causes • Significantly premature/overdue • Failure of passive transfer • Poor farm management (dirty foaling environment, etc) Predisposing Factors - FPT • Poor quality colostrum • Inadequate colostrum intake • Inability to nurse (inability to stand, rejection by dam) Organisms Commonly Causing Septicemia in Foals (Geographically-specific –> southern Ontario) • Streptococcus zooepidemicus • Escherichia coli • Klebsiella pneumoniae Routes of Infection • Umbilicus • Gastrointestinal Tract • Respiratory Tract

  22. THERAPEUTIC PLAN • Immunologic support • Commercially available plasma – 2L Polymune Plasma IV • Factored into fluid replacement calc’ns • Cardiovascular support • Lidocaine CRI (20 ug/kg/hr) • KCl CRI (0.5 mEq/kr/hr) • Oxygen therapy • Via nasal canula – 5L/min flow • Nutrition • Mare’s milk and milk replacer via nasogastric feeding tube, gradually increasing quantity up to 25% bodyweight • Monitoring • TPR/arterial blood gas analysis q6hrs, continuous ECG, urine/fecal output • Repeat CBC/biochem/coag panel in 24hrs • Active warming until rectal temp. >37°C • Antimicrobial therapy • Cefotaxime - 3rd generation cephalosporin - 40 mg/kg q6hrs IV • Empirical therapy initiated before blood culture results due to severity of illness • Broad spectrum, has activity against most gram positives and gram negatives • Anti-inflammatory • Flunixin meglumine (NSAID) - 0.5 mg/kg BID IV x 3 days • Also has anti-endotoxic effects • Fluid therapy • Crystalloid: Plasmalyte A (isotonic sol’n) + 2.5% dextrose – rate: 75 mL/kg/day IV

  23. BLOOD GAS/E-LYTE TRENDS Significant Trends: • paO2/sO2: ↑ oxygenation over time with nasal oxygen therapy • Lactate: ↑ over time reflects improved perfusion initially – should decrease over time • paCO2: ↓initially due to manual ventilation, then remains at the high end of the normal range • Glucose: ↑ initially in response to emergency therapy, then returns to hypoglycemic levels (normalized later when dextrose was added to IV fluids)

  24. CASE PROGRESSION – DAY 2 • Data • TPR normal but depression, weak pulses, petechiae persist • Arterial blood gas: pO2/sO2 improved but ↑pCO2 • CBC: neutrophilia, thrombocytopenia • Biochem: improved TP (globulins still low), hepatic/renal enzymes remain ↑ • Coag Panel: no change from admission (↑PT/PTT) • Assessment • Stable, improved cardiovascular and respiratory function, immune system responding appropriately to septicemia (↑ neutrophils) • Plan • Add inhaled bronchodilator (salbutamol) and corticosteroid (fluticasone) to improve pulmonary function, caffeine (500 mg PO SID) to ↑ resp rate • Reduce lidocaine CRI/discontinue KCl, continue to monitor heart rhythm

  25. CASE PROGRESSION – DAYS 3-5 • Data • Brighter, able to stand and nurse from a bottle, hyperemia/petechiae of mucus membrane resolved • TPR and heart rhythm normal when lidocaine CRI discontinued, strong peripheral pulses • CBC/biochem/coagulation abnormalities improving • Blood culture results: no significant pathogens cultured • Assessment • Clinical/clinicopathological condition improving • Plan • Dam still not accepting foal, decision made to use a nurse mare • Continue antimicrobials, IV fluids, and bottle feedings with milk replacer

  26. CASE PROGRESSION – DAY 6 • Plan: • Discharged from hospital under close supervision by rDVM to be fostered onto a nurse mare • Medication: • Ceftiofur: 3rd generation cephalosporin with activity again gram positive and gram negative organisms) • 2 mg/kg IM BID for two weeks • Nutrition: • Ensure adequate caloric intake from nurse mare (monitor body weight/condition)

  27. PROGNOSIS • Post-resuscitation: • Prognosis following a rapid resuscitation can be quite good • Negative prognostic indicators: use of multiple drugs, ETCO2 <15 mmHg • Septicemic foals: • Several studies have looked at prognosis of septicemic foals • Survival to discharge varies from 30-75% (50-60% is common) • Prognosis for future performance: • Long term survival has not been closely studied • New Bolton Centre study: fewer NICU survivors are registered/enter one race than a matched control population • However, there was no difference in number of starts/winnings for those that started in at least one race

  28. CLIENT EDUCATION – PREVENTION OF SEPTICEMIA Ensure adequate passive transfer (Quality, Quantity, Timing) • Assess quality of colostrum – measure specific gravity • >1.050 is adequate, >1.090 is ideal • Ensure sufficient quantity has been ingested (test IgG levels at 12-24 hrs of age) • Timing: should nurse by 3 hrs (ideal), significantly ↓ gut absorption by 12 hrs • Administer plasma promptly if required (IgG <800 mg/dL) Maintain a clean environment • Disinfect foaling stall between mares • Wash mare’s perineum, vulva, and udder after foaling before nursing Attention to the umbilicus • Chlorhexidine umbilical dip (ideal) or povidone-iodine 2x/day for 3 days • Observe umbilicus for signs of omphalophlebitis or patent urachus

  29. EARLY SIGNS OF TROUBLE IN YOUNG FOALS Careful attention particularly to high-risk foals: • Mare illness during parturition or history of sick foals from dam • Premature parturition or significantly overdue • ‘Red bag’ delivery (premature placental separation) Normal timeline of activity following parturition: • Sit sternal immediately, stand in 1-2hrs, nurse in 3hrs • Veterinary attention recommended if not nursing within 6hrs Normal neonatal foal behaviour: • Sleep soundly without disturbance but easy to rouse, stand easily, urinate/nurse immediately after standing, nurse 5-8 times per hour Signs to watch for: • Full udder, ↓ activity, difficulty to stand, lameness, ↑ respiratory effort, diarrhea, colic, grinding teeth, abdominal distention, swollen umbilicus/dripping urine

  30. OUTCOME This foal did not survive to weaning – indicated in mare’s production record when sold at auction in the fall– cause of death not available

  31. ACKNOWLEDGMENTS Thanks to Dr. Darren Wood, DVM, DVSc, DACVP for assistance with clinical pathology interpretation Thanks to Dr. Ashley Whitehead for providing images Thanks to Dr. Joanne Hewson, DVM, PhD, DACVIM (senior clinician and mentor)

  32. REFERENCES & FURTHER READING • Axon, JE, Palmer, JE. Clinical pathology of the foal. Vet Clin Equine 2008;24:357-385. • Axon, JE, Palmer, JE. Short- and long-term athletic outcome of neonatal intensive care unit survivors. Proceedings of the 45th AAEP Annual Convention, Albuquerque, New Mexico, 1999. • Palmer, JE. Neonatal foal resuscitation. Vet Clin Equine 2007;23:159-182 • Pierce, S. Foal care from birth to 30 days: a practitioner’s perspective. Proceedings of the 49th AAEP Annual Convention, New Orleans, Louisiana, 2003. • Sanchez, LC. Equine neonatal sepsis. Vet Clin Equine 2005;21:273-293. • Vaala, WE, House, JK. Perinatal adaptation, asphyxia, and resuscitation. In: Large Animal Internal Medicine, 3rd ed. Ed: Smith B, Mosby, St. Louis. 2002. Pp. 272-275.

More Related